New Phase Research & Development | Knoxville, TN

Research site

(Unclaimed)

Location

6914 Office Park Circle, Knoxville, Tennessee, United States of America

Site insights

Top conditions

Top treatments

LY3298176

Tirzepatide

Ranolazine

Metformin

Bococizumab

Testosterone

MD-7246

Loperamide

RPL554

Ondansetron

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 36 total trials

A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

The aim of this study is to assess whether IW-3300 is safe and works for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS). The m...

Enrolling

Interstitial Cystitis

Bladder Pain Syndrome

Drug: Placebo

Drug: IW-3300 rectal foam

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus (GALACELA)

A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily fo...

Enrolling

Systemic Lupus Erythematosus

Drug: GLPG3667

Drug: Placebo

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (RSVictory)

The main purposes of Part A of this study are to evaluate the safety, tolerability, and immunogenicity of mRNA-1345 coadministered with a seasonal in...

Active, not recruiting

Respiratory Syncytial Virus

Biological: mRNA-1273.214

Biological: mRNA-1345

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Obicetrapib

Drug: Placebo

Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and sa...

Enrolling

Post Surgical Neuropathic Pain

Drug: capsaicin 0.04% topical system

Drug: Qutenza (capsaicin) 8% topical system